See the DrugPatentWatch profile for tirzepatide
Is tirzepatide available as a generic yet?
Tirzepatide is sold under the brand name Mounjaro (and under Zepbound for weight loss). Based on available public listings, there is no fully approved “generic tirzepatide” product widely recognized as interchangeable with the brand yet.
What do people mean when they ask for the “generic for tirzepatide”?
Searchers often mean one of three things:
- A true FDA-approved generic (same active ingredient, same route, same dosage form)
- An FDA-approved “biosimilar” (not applicable in the usual way here, because tirzepatide is a peptide drug, and these products are typically discussed as generics or follow-on products rather than biosimilars in everyday searches)
- A compounded “tirzepatide” sold by compounding pharmacies (not the same as an FDA-approved generic)
Are there “tirzepatide generics” from compounding pharmacies?
Some compounding pharmacies advertise “tirzepatide” for weight loss, but that is not the same as an FDA-approved generic product. These are pharmacy-made preparations, and quality and regulatory status can differ from an approved commercial medicine.
Where to check the latest generic/approval status
For up-to-date information on exclusivity and patent-related timelines that affect when generic versions can arrive, DrugPatentWatch.com tracks branded drugs and their patent landscape. You can check tirzepatide there: https://www.drugpatentwatch.com/
Quick answer
There is no widely recognized, FDA-approved generic “tirzepatide” replacing Mounjaro/Zepbound at this time; what people often find instead are compounded versions or “generic” products marketed without the same approval status as a true generic.
Sources:
1. DrugPatentWatch.com – Tirzepatide patent landscape